Atom Investors LP - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 53 filers reported holding PROQR THRAPEUTICS N V in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
Atom Investors LP ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2023$17,039
-19.8%
13,1070.0%0.00%
-50.0%
Q2 2023$21,233
-23.9%
13,1070.0%0.01%
-46.7%
Q1 2023$27,918
-59.3%
13,107
-29.2%
0.02%
-55.9%
Q4 2022$68,531
+226.3%
18,522
-35.7%
0.03%
+385.7%
Q3 2022$21,000
-12.5%
28,821
-5.3%
0.01%
-30.0%
Q2 2022$24,000
-14.3%
30,4220.0%0.01%
-23.1%
Q1 2022$28,00030,4220.01%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q2 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders